5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Sell
49
VSTM Quote, Financials, Valuation and Earnings
Last price:
$6.94
Seasonality move
:
14.67%
Day range:
$6.50 - $8.00
52-week range:
$2.10 - $13.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
27.44x
Volume:
3.6M
Avg. volume:
1.2M
1-year change:
-39.12%
Market cap:
$357.3M
Revenue:
$10M
EPS (TTM):
-$3.72
Analysts' Opinion
-
Consensus RatingVerastem has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.75, Verastem has an estimated upside of 92.72% from its current price of $6.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.00 representing -15.27% downside risk from its current price of $6.94.
Fair Value
-
According to the consensus of 7 analysts, Verastem has 92.72% upside to fair value with a price target of $13.75 per share.
VSTM vs. S&P 500
-
Over the past 5 trading days, Verastem has underperformed the S&P 500 by -6.22% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Verastem does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Verastem has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Verastem reported revenues of $10M.
Earnings Growth
-
Verastem has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Verastem reported earnings per share of -$1.55.
Enterprise value:
309.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.95x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-59.91%
Net Income Margin (TTM):
--
Return On Equity:
-120.71%
Return On Invested Capital:
-78.01%
Operating Margin:
-182.77%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$72.9M | -$92.1M | -$115M | -$31.1M | -$31.6M | |
| EBITDA | -$71.5M | -$83.2M | -$125.8M | -$26.2M | -$63.2M | |
| Diluted EPS | -$4.56 | -$4.09 | -$3.72 | -$1.03 | -$1.55 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $144.9M | $105.7M | $92.9M | $143.7M | $95M | |
| Total Assets | $154.3M | $108.7M | $95.1M | $149.7M | $101.5M | |
| Current Liabilities | $17.1M | $18.6M | $21.7M | $26.4M | $31M | |
| Total Liabilities | $39.1M | $21.1M | $47.7M | $92.3M | $130.4M | |
| Total Equity | $115.3M | $87.6M | $47.4M | $57.4M | -$28.9M | |
| Total Debt | $19.1M | $249K | $24.8M | $40.1M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$63.7M | -$86.5M | -$104.8M | -$29.7M | -$25.1M | |
| Cash From Investing | $66.2M | -$44.4M | $60M | $12.4M | -- | |
| Cash From Financing | $51.8M | $134.2M | $54.8M | -$446K | $742K | |
| Free Cash Flow | -$63.7M | -$86.5M | -$104.8M | -$29.7M | -$25.1M | |
VSTM
Sector
Market Cap
$357.3M
$33.9M
Price % of 52-Week High
51.33%
44.2%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-39.12%
-40.43%
Beta (5-Year)
0.855
0.660
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.06
200-day SMA
Buy
Level
$4.56
Bollinger Bands (100)
Buy
Level
4.92 - 6.84
Chaikin Money Flow
Sell
Level
-20.7M
20-day SMA
Buy
Level
$6.42
Relative Strength Index (RSI14)
Buy
Level
55.34
ADX Line
Buy
Level
25.81
Williams %R
Neutral
Level
-48.7603
50-day SMA
Buy
Level
$6.35
MACD (12, 26)
Buy
Level
0.29
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
26.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-15.3464)
Sell
CA Score
(Annual)
Level (-6.7272)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (9.5704)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Stock Forecast FAQ
In the current month, VSTM has received 7 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VSTM average analyst price target in the past 3 months is $13.75.
-
Where Will Verastem Stock Be In 1 Year?
According to analysts, the consensus estimate is that Verastem share price will rise to $13.75 per share over the next 12 months.
-
What Do Analysts Say About Verastem?
Analysts are divided on their view about Verastem share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Verastem is a Sell and believe this share price will drop from its current level to $8.00.
-
What Is Verastem's Price Target?
The price target for Verastem over the next 1-year time period is forecast to be $13.75 according to 7 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VSTM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Verastem is a Buy. 7 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VSTM?
You can purchase shares of Verastem via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Verastem shares.
-
What Is The Verastem Share Price Today?
Verastem was last trading at $6.94 per share. This represents the most recent stock quote for Verastem. Yesterday, Verastem closed at $6.94 per share.
-
How To Buy Verastem Stock Online?
In order to purchase Verastem stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
99
DAVE alert for May 9
Dave [DAVE] is up 4.54% over the past day.
Buy
52
QDEL alert for May 9
QuidelOrtho [QDEL] is down 0.36% over the past day.
Buy
61
TPC alert for May 9
Tutor Perini [TPC] is up 4.82% over the past day.
